A B S T R A C T Thrombin converts fibrinogen to fibrin monomer by cleaving fibrinopeptides A and B (FPA and FPB) from the amino terminal ends of the A(a) and B (P) chains. A radioimmunoassay capable of measuring the A peptide in human blood as an index of thrombin action in vivo has been described previously. This paper describes the development of a radioimmunoassay for FPB and the use of both assays in the demonstration of distinctive patterns of cleavage of the amino terminal ends of the A(a) and B(P) chains of fibrinogen by various enzymes.
A B S T R A C T Thrombin converts fibrinogen to fibrin monomer by cleaving fibrinopeptides A and B (FPA and FPB) from the amino terminal ends of the A(a) and B (P) chains. A radioimmunoassay capable of measuring the A peptide in human blood as an index of thrombin action in vivo has been described previously. This paper describes the development of a radioimmunoassay for FPB and the use of both assays in the demonstration of distinctive patterns of cleavage of the amino terminal ends of the A(a) and B(P) chains of fibrinogen by various enzymes.
Antisera were raised in rabbits to a synthetic analogue of FPB coupled to bovine serum albumin. FPB analogue was coupled to desaminotyrosine and radiolabeled with 'I by the chloramine-T technique. The radiolabeled peptide was bound by the antiserum, and binding was inhibited by synthetic or native FPB. Unbound tracer was separated from bound tracer by charcoal adsorption. The sensitivity of the assay was such that 50% inhibition of binding of the tracer was caused by 1.25 ng of the native FPB.
Fibrinogen was treated with thrombin, plasmin, trypsin, Reptilase, and an extract of the venom from Ancistrodon contortrix contortrix (ACC). After ethanol precipitation and centrifugation, dialysates of enzymatically altered fibrinogen were assayed for FPA and FPB. The action of thrombin on fibrinogen resulted in a rapid release of FPA and a slower release of FPB. Plasmin cleaved a segment(s) of the B (f) chain which included FPB but cleaved no detectable FPA-containing material for the first 2 h of incubation. In the case of plasmin-treated fibrinogen, the dialysates had been further treated with thrombin before being assayed for FPA and FPB. Trypsin rapidly cleaved both peptides, the B before the A. Reptilase cleaved only FPA in 24 h. ACC cleaved FPB at a rapid rate, with a slower cleavage of FPA. The distinctive cleavage patterns produced by the serine proteases may be useful in interpreting the levels of FPA and FPB measured in human blood and in studying the generation of FPA and FPB in clinical blood samples.
INTRODUCTION
Coagulation of fibrinogen follows its enzymatic conversion by thrombin to fibrin monomer in a limited proteolytic reaction in which fibrinopeptides A and B (FPA and FPB) 1 are removed (1, 2 Preparation of immunogenu. Synthetic FPB analogue was coupled to bovine serum albumin as follows. At room temperature, 2 ml 0.021 M glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.0) was added dropwise with constant stirring to a mixture of 8 mg FPB analogue and 40 mg bovine serum albumin in 4 ml 0.1 M sodium phosphate buffer (pH 7.0). After 2 h of stirring, the reaction mixture was dialyzed for 24 h against several changes of 0.15 M sodium barbital-buffered saline (pH 7.4) and then lyophilized. The final yield was 96 mg of material of which approximately 50% was buffer salts and sodium chloride.
Antisera. 8 mg of the lyophilized material containing approximately 4 mg of the bovine serum albumin-FPB conjugate was dissolved in 2 ml 0.15 M NaCl and thoroughly mixed in a syringe with 2 ml of complete Freund's adjuvant until it had thickened. After preimmunization sera 'CTA, Committee on Thrombolytic Agents. formed which soon turned white. The mixture was then extracted with 15 ml of a 1: 1 (vol/vol) chloroformethyl ether solution. After centrifugation at 500 g for 5 min at room temperature three phases separated; a lower phase of chloroform-ethyl ether, a dense white emulsion at the interphase, and at the top, a clear water phase. The water phase was re-extracted with 15 ml chloroform-ethyl ether and lyophilized. The lyophilized sample was dissolved in 1 ml of 0.1 M NH4HCOs, applied to a 20 X 1.2-cm column of Biogel P-2 (Calbiochem, San Diego, Calif.) suspended in 0.1 M NHJHCO3, and eluted with the same buffer. The contents of the 11th ml of eluate showed a peak of ninhydrin reactivity after alkaline hydrolysis as well as maximal absorbance at 280 nm. The peptide content of the fraction was estimated from the ninhydrin reactivity, and the tyrosine content was estimated by comparing the absorbance at 280 nm of the fraction with that of standard solutions of tyrosine and desaminotyrosine. From these data. it was estimated that the coupling of desaminotyrosine to the synthetic FPB analogue was approximately 1:1 on a molar basis.
The desaminotyrosine coupled peptide was radiolabeled by the method of Hunter and Greenwood (8) . 30 ,ul 0.5 M sodium phosphate buffer (pH 7.5) and 5 ,ul carrier-free 4. 900-pl aliquots of fibrinogen at 0.5 mg/ml were incubated at 37'C with 100 ,ul of enzyme for intervals ranging from 5 to 120 min and for 24 h. Control samples of fibrinogen were incubated with buffer in place of enzyme at 370C for 120 min and 24 h. The reaction was stopped and the fibrinogen precipitated by the addition of 1 ml of ethanol to each sample. The fibrinogen was deposited by centrifuging at 4,800 g at 40C for 10 min. The top 1 ml of supernatant solution was transferred to a fresh tube and recentrifuged under the same conditions. Of this, the top 0.5 ml was pipetted into a segment of dialysis tubing (i inch inflated, Union Carbide Corp.) and dialyzed against 4.5 ml of 0.1 M NaCl buffered with 0.05 M TrisHCl at pH 8.6 with 0.1% ovalbumin. Dialysis was carried out for 24 h at 10'C with constant mechanical rotation at 1 revolution per 6 min on a Bellco roller drum, (Bellco Glass, Inc., Vineland, New Jersey). The dialysates were stored at -80°C and subsequently assayed for FPA using antiserum R33 (4) and for FPB using antiserum RB29 (Table II) . For the experiments in which fibrinogen was incubated with plasmin, the dialysates were further treated with thrombin 1 U/ml for 2 h at 37°C before testing to be able to quantitate in molar terms the presence of fragments of the A (a) and B (p) chains containing the A and B peptides. For each experiment, the values obtained for FPA and FPB in the dialysates were corrected by a factor obtained by similarly processing and dialyzing aliquots of radiolabeled peptide. 1 ml each of radiolabeled FPA and FPB was precipitated with 50% ethanol, centrifuged, and dialyzed along with the samples, and the recovery of tracer in the dialysates was determined. To determine the extent to which proteins of different sizes would pass through the dialysis membrane, the following experiment was performed. Trasylol (mol wt 6,000), ribonuclease (mol wt 13,700), chymotrypsinogen (mol wt 25,000), ovalbumin (mol wt 45,000), and albumin (mol wt 67,000) were each dialyzed for 24 h against 0.1 M NaCl buffered with 0.05 M Tris-HCI at pH 7.4, and the recovery of protein in the dialysate was determined spectrophotometrically. The recovery of Trasylol after 24 h of dialysis was 22%, and was 1% or less for each of the other materials.
Calculation of enzyme and substrate concentrations. The enzymatic cleavage of fibrinogen was performed at a substrate concentration of 0.45 mg/ml (1. M, assuming a sp act of 2,500 U/mg.! The plasmin concentration used was 0.01 mg/ml. Assuning a mol wt of 75,000 (9) , the concentration would be 1.25 X 10-M. Since the sp act of the plasmin preparation was 10 U/mg and sp act of 25 U/mg have been described (10), it is possible that the molar plasmin concentration was less than calculated above. The trypsin concentration was 10' mg/ml which would be 4.2 X 10-' M assuming a mol wt of 24,000.
RESULTS
Antisera to human and bovine serum albumin and two antisera to fibrinogen bound insignificant amounts of radiolabeled peptide (Table II) . Preimmunization antisera from rabbits RB22, RB23, RB24, and RB29 bound insignificant amounts of radiolabeled peptide; however, after 3 mo of immunization with FPB-albumin conjugate, these antisera bound significant amounts of radiolabeled FPB (Table II) . Antisera from rabbits RB22 and RB29 were the most active and were used in the subsequent experiments.
Binding of the radiolabeled peptide by antiserum and inhibition of binding by FPB was demonstrated by gel filtration experiments. As shown in Fig. 1 RB22 and RB29 both cross-reacted with fibrinogen, but their patterns of reactivity were different. In the case of antiserum RB29, fibrinogen was only slightly less reactive than FPB in inhibiting binding of the tracer (Fig. 3a) . In the case of antiserum RB22, fibrinogen was significantly less reactive than FPB in inhibiting binding of the tracer, so that up to 400 pmol of fibrinogen inhibited binding by only 38% (Fig. 3b) . Application of the FPB assay and the previously developed FPA assay to the study of the kinetics of enzymatic cleavage of the two peptides from fibrinogen confirmed that different enzymes had distinctive cleavage patterns. Incubation of fibrinogen with thrombin resulted in an initial rapid release of FPA, with a slower release of FPB (Fig. 4) . The rate of release of FPB appeared to increase after cleavage of 1 mol FPA per mol of fibrinogen. At 60 min 1.8 mol FPA and 1.4 mol FPB had been recovered per mol of fibrinogen. Incubation of fibrinogen with plasmin resulted in cleavage of a segment or segments of the amino terminal end of the B(P) chain which included the B peptide. There was no detectable release of FPAcontaining material for the first 2 h of incubation (Fig.  5) . After 24 h of incubation considerable amounts of FPA-containing segments had been released equivalent to the total amount of FPB-containing material. Incubation of fibrinogen with trypsin resulted in a rapid cleavage of the amino terminal ends of both the A(a) and B (i3) chains. The B peptide or a segment containing it appeared somewhat faster than the A (Fig.  6 ). There appeared to be an increase in the cleavage rate for both peptides after 15 min incubation. After 24 h, 2.2 mol of FPB immunoreactivity and 1.6 mol of FPA immunoreactivity were recovered per mol of fibrinogen.
The effects of the two snake venoms tested on fibrinogen were also distinctive. Reptilase cleaved the A peptide from fibrinogen completely in 2 h, with no detectable release of the B peptide even after 24 h of incubation (Fig. 7) . On the other hand, ACC cleaved the B peptide from fibrinogen at a rapid initial rate, with a slower release of the A peptide (Fig. 8) FIGURE 6 Cleavage of FPA and FPB from fibrinogen by trypsin. The fibrinogen concentration was 0.45 mg/ml, the trypsin concentration was 10-' mg/ml, the pH 7.4, ionic strength 0.15 M, and temperature 370C.
DISCUSSION
The data indicate that a specific and sensitive radioimmunoassay for human FPB can be performed with the use of radiolabeled N-desaminotyrosyl FPB and antisera from rabbits immunized with FPB analoguealbumin conjugates. The assay is sensitive enough to measure accurately 1.25 ng of native FPB (50% inhibition of binding) (Fig. 2) . A fourfold increase in sensitivity can be obtained by using a preincubation technique. The specificity of the assay for FPB is high in comparison with other proteins (Table III) . Crossreactivity with fibrinogen differed significantly with the two antisera tested. With antiserum RB29 crossreactivity was nearly complete, whereas much more limited cross-reactivity occurred with antiserum RB22. This result implies that the antigenic determinant on the peptide which reacts with antiserum RB22 is partly occluded in the intact fibrinogen molecule. When dialysates of streptokinase-treated plasma were tested with RB22 antiserum, a five-fold increase in immunoreactivity occurred after treatment of the dialysate with thrombin (data not shown). Since the dialysis membrane is relatively impermeable to large molecules, it is likely that the dialysate of streptokinase-treated plasma contains small molecular weight peptides (possibly B (P) produced by plasmin cleavage from the NH2-terminal end of the B (P) chain of fibrinogen, and that the antigenic determinant which reacts with RB22 is also partly hidden in these small peptides. If these speculations are correct, the results are analogous to the finding that in the FPA assay the R2 antigenic determinant is unavailable in the A(a) 1-23 segment (4) . The practical consequence of such results would be that it would be possible to identify the presence or absence of the B (P) 1-42 peptide in clinical blood samples by immunochemical means as was done for the FPA assay (4). In considering the kinetics of peptide cleavage by enzymes, the finding that thrombin cleaves FPA faster than FPB confirms the observations of Blombdck and Vestermark (2), of Bettelheim (11), of Shainoff and Page (12) , and of Abildgaard (13) . The rate of FPA cleavage in the present study is similar to that noted by Abildgaard (13) and by Blombdck and Vestermark (2) . The signal for the release of FPB by thrombin is not known but it appears from the data in Fig. 4 Kierulf (17) , and Kowalska-Loth, Gardlund, Egberg, and Blombick (18) all noted the absence of FPB in fibrinogen derivatives resulting from limited plasmin proteolysis. The size and composition of FPB containing peptides cleaved by plasmin is not known. In this study, the peptides released from enzyme-treated fibrinogen were extracted by ethanol precipitation, centrifugation, and dialysis. The results of the experiments in which proteins of different sizes were dialyzed indicate that the passage of molecules of 13,700 mol wt or greater is very slow. Hence the extracts almost certainly do not contain fragment E which is approximately 60,000 mol wt (18) . Although the Arg (14)-Gly (15) bond in sulfitolyzed B(P) chains of fibrinogen is not cleaved by plasmin, about nine peptide bonds between Gly (15) and Ala (59) on the B(fi) chain are susceptible to plasmin cleavage (19) , and the FPB containing segments monitored in the present study could reflect cleavage at one or more of these sites. In the present study the extracts of plasmin-treated fibrinogen were treated with thrombin before assay. In this way the number of moles of FPB containing peptide in the dialysate could be quantitated. The finding that substantial quantities of FPA containing peptide were released after 24 h may be compared with the findings of other workers on the fibrinopeptide content of plasmin degraded fibrinogen. Kowalska-Loth and colleagues (18) found that preparations of fragment E derived from plasmindegraded fibrinogen still released FPA on treatment with thrombin. Budzynski and colleagues (16) and Mosesson, Finlayson, and Galanakis (20) have observed that early E contains FPA, while late E lacks FPA. It is difficult to exclude the presence of minute amounts of thrombin in the incubation mixture. Thrombin at 2 X 10-U/ml could produce the amount of FPA released in 24 h in Fig. 5 . In experiments in which hirudin was in the incubation mixture, significantly smaller amounts of FPA immunoreactivity were released. It is possible that small amounts of thrombin were generated over 24 h of incubation, which in the absence of hirudin acted to cleave the FPA. The fact that no detectable immunoreactivity was released in the first 120 min implies that a change in the reactants was required for FPA immunoreactivity release. Possible changes include thrombin generation, a specific molecular change in the fibrinogen molecule, or reduction in the competitive inhibitory effect of alternative cleavage sites as the concentration of these drops during continuing proteolysis.
The cleavage of both peptides from fibrinogen by trypsin (Fig. 6) is consistent with the findings of previous investigators. Pechet and Alexander (21) and Mihalyi and Godfrey (22) found that early in the course of trypsin action, fibrinogen showed no further reactivity to thrombin, suggesting that the bonds susceptible to thrombin had been cleaved. Wallen found that trypsin cleaves the bonds susceptible to thrombin as well as other sites in the A(a) and B (Q) chains (19) . The fact that FPB cleavage is more rapid than FPA cleavage has not been described previously. The finding that Reptilase cleaves the A peptide but not the B (Fig. 7) confirms the observations of Blombick and Yamashina (1) . The finding that ACC cleaves the B peptide at a faster initial rate than the A (Fig. 8) is consistent with the report of Herzig, Ratnoff, and Shainoff, who studied the effects of the whole venom on fibrinogen (23) .
The results of the enzyme studies show that the serine proteases thrombin, plasmin, and trypsin do have distinctive in vitro patterns of cleavage of the NH2-terminal ends of the A(a) and B(f) chains of fibrinogen. In addition, it is clear that there are marked differences in the quantitative effectiveness with which they cleave this end of the molecule. Thrombin is the most effective, trypsin next and plasmin is the least effective. The distinctive patterns of cleavage of the NH2-terminal ends of the A(a) and B (P) chains of fibrinogen by different enzymes may provide a method for specifically indentifying the action of the enzymes in clinical blood samples. Generation rates of the two fibrinopeptides may be studied in clinical blood samples as well as the relative levels of the peptides in the blood. The data from the present studies indicate that FPA immunoreactivity is more likely to reflect thrombin action and FPB immunoreactivity plasmin action in vivo.
